Alaunos Therapeutics Inc. – Filings and Transcripts

NASDAQ: TCRT
Share price (3/27/26): $2.98
Market cap (3/27/26): $6.651 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus unintentially filed late

Shelf registration – amended

Initial registration of new securities

Shelf registration – amended

Shelf registration – amended

Ownership Filter

Jerman Michael Allen

Postma Robert W

News Filter

Announces Positive Preclinical Proof-Of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

Termination of Material Definitive Agreement, Material Modification to Rights of Security Holders, Other Events, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC